| Early Rheumatoid Arthritis Lung Disease Study (NCT03192267) | University of Nebraska | 2017-03-31 |
| A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice (NCT03291457) | Hoffmann-La Roche | 2017-03-30 |
| Physica System Total Knee Replacement Registry Study (NCT03048201) | Limacorporate S.p.a | 2017-03-24 |
| Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan (NCT03348046) | Hikma Pharmaceuticals LLC | 2017-03-23 |
| Clinical Evaluation of the TITAN™ Total Shoulder System (NCT03245320) | Smith & Nephew, Inc. | 2017-03-20 |
| The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis (NCT03331393) | Bristol-Myers Squibb | 2017-03-16 |
| Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis (NCT03110094) | Rennes University Hospital | 2017-03-13 |
| Efficacy, Radiographic and Laboratory Changes in Refractory Rheumatoid Arthritis Patients Treated With H.P. Acthar Gel (NCT03082573) | Iraj Sabahi Research Inc. | 2017-03-03 |
| The Norwegian Drug Monitoring Study (NCT03074656) | Diakonhjemmet Hospital | 2017-03-01 |
| Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis (NCT03025308) | Alfasigma S.p.A. | 2017-02-28 |
| Dental Prophylaxis and Rheumatoid Arthritis (NCT03087240) | University Hospital Heidelberg | 2017-02-28 |
| A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis (NCT03161457) | JHL Biotech, Inc. | 2017-02-27 |
| A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents (NCT03670667) | Bristol-Myers Squibb | 2017-02-22 |
| Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis. (NCT03667131) | University of Guadalajara | 2017-02-13 |
| Non-Interventional, Multicenter Bicontact® E PMCF Study (NCT03442855) | Aesculap AG | 2017-02-01 |
| Interaction Between Immune Cells and Bacteria Associated With Periodontitis (NCT03225950) | University of Copenhagen | 2017-02-01 |
| ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis) (NCT02941055) | Göteborg University | 2017-02-01 |
| Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients (NCT02997605) | University Hospital, Toulouse | 2017-01-31 |
| A Study of the Efficacy and Safety of Tocilizumab for Confirmed Rheumatoid Arthritis (RA) Participants in Clinical Practice (NCT02616328) | Hoffmann-La Roche | 2017-01-26 |
| Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease (NCT02760433) | R-Pharm International, LLC | 2017-01-25 |
| Role of Hydroxychloroquine to Improve Endothelial Dysfunction in Patients With Rheumatoid Arthritis (NCT03085940) | Indonesia University | 2017-01-20 |
| The Effects of Hyperbaric Oxygen on Rheumatoid Arthritis (NCT02984943) | David Grant U.S. Air Force Medical Center | 2017-01-19 |
| A Phase 3 Study of NI-071 in Participants With Rheumatoid Arthritis (RADIANCE) (NCT02990806) | Nichi-Iko Pharmaceutical Co., Ltd. | 2017-01-19 |
| Characterization of Non-Steroidal Anti-Inflammatory Drug (NSAID) Intake in Rheumatoid Arthritis (RA) Participants on Tocilizumab (RoACTEMRA®) Treatment (NCT03112213) | Hoffmann-La Roche | 2017-01-12 |
| A New Mode of Action of Anti-TNF, Reverse Signaling, in Rheumatoid Arthritis (NCT03216928) | University Hospital, Toulouse | 2017-01-01 |
| A Musculoskeletal Ultrasound Program to Improve Disease Modifying Anti-Rheumatic Drugs Adherence in Rheumatoid Arthritis (NCT02671838) | Singapore General Hospital | 2017-01-01 |
| OPAM-IA: Using Digital Activity Trackers to Improve Physical Activity in Inflammatory Arthritis (NCT02554474) | University of British Columbia | 2017-01-01 |
| A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy (NCT03001219) | Hoffmann-La Roche | 2016-12-22 |
| Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate (NCT02969044) | Pfizer | 2016-12-20 |
| Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis (NCT02862574) | Gilead Sciences | 2016-12-15 |
| RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis (NCT03016260) | TcLand Expression S.A. | 2016-12-01 |
| A Study to Evaluate the Long-Term Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Rheumatoid Arthritis Enrolled in Study GA29350 (NCT02983227) | Genentech, Inc. | 2016-11-30 |
| Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries (NCT02632890) | Bristol-Myers Squibb | 2016-11-29 |
| A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics (NCT02960490) | Eisai Co., Ltd. | 2016-11-26 |
| Metabolome Analysis in Patients With Rheumatoid Arthritis (NCT02960958) | The Catholic University of Korea | 2016-11-20 |
| Multidisciplinary Team Care in Rheumatoid Arthritis (NCT03099668) | National University Hospital, Singapore | 2016-11-17 |
| Ticagrelor in Methotrexate-Resistant Rheumatoid Arthritis (NCT02874092) | NYU Langone Health | 2016-11-15 |
| Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate (NCT02996500) | Pfizer | 2016-11-10 |
| French National Registry: ART REGISTRY (Observational Study) (NCT03062865) | Assistance Publique - Hôpitaux de Paris | 2016-11-01 |
| RADAR1- Trial of a New Blood Sample Method (Remote Arthritis Disease Activity MonitoR) (NCT02809547) | University of Ulster | 2016-11-01 |
| A Novel Mobile App & Population Management System to Manage Rheumatoid Arthritis Flares (NCT02822521) | Brigham and Women's Hospital | 2016-11-01 |
| Predictive Analytics for Theranosis in RA (NCT02928276) | DNAlytics | 2016-11-01 |
| Transplantation of Autologous Bone Marrow Derived Stem Cells in Patients With Rheumatoid Arthritis (NCT03067870) | Stem Cells Arabia | 2016-11-01 |
| Educational Intervention to Improve Patient-Physician Awareness of Cardiovascular Risk in Rheumatoid Arthritis. (NCT03495791) | Rush University Medical Center | 2016-10-31 |
| Safety, Tolerability, PK and PD of Biosimilar Drug Ritumax® Compared to Original Drug MabThera® (NCT03061838) | Biointegrator LLC | 2016-10-27 |
| A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to Methotrexate (NCT02960438) | Eisai Co., Ltd. | 2016-10-20 |
| National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life (NCT02925338) | Pfizer | 2016-10-19 |
| Lipids, Inflammation, and CV Risk in RA (NCT02714881) | Brigham and Women's Hospital | 2016-10-17 |
| PK, PD, Safety, and Efficacy of SAIT101 Versus MabThera® Versus Rituxan® in Patients With Rheumatoid Arthritis (NCT02819726) | Archigen Biotech Limited | 2016-10-11 |
| Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 ) (NCT03403140) | Gema Biotech S.A. | 2016-10-06 |
| Outcome After Total Knee Arthroplasty Under General or Spinal Anesthesia (NCT03364088) | Riku Antero Palanne | 2016-10-03 |
| Treatment Outcome and Prognostic Factors for Rheumatoid Arthritis (RA) Patients With Interstitial Lung Disease (ILD) (NCT03099525) | Hanyang University | 2016-10-01 |
| Ultrasound Assessment of Rheumatoid Arthritis Patients Who Changed Diet (NCT02881307) | Veena Ranganath, MD, MS | 2016-10-01 |
| REU-stop - Effect of Intensive Smoking Cessation Intervention on Smoking Cessation and Disease Activity in Patients With Rheumatoid Arthritis. (NCT02901886) | Glostrup University Hospital, Copenhagen | 2016-10-01 |
| Standard Versus High Dose Inactivated Influenza Vaccine in RA (NCT02936180) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2016-10-01 |
| Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting (NCT02037737) | Bristol-Myers Squibb | 2016-09-30 |
| EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis (NCT02648035) | Hoffmann-La Roche | 2016-09-22 |
| Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate (NCT02885181) | Gilead Sciences | 2016-09-21 |
| A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate (NCT02884635) | Astellas Pharma Inc | 2016-09-16 |
| Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis (NCT02919475) | Akros Pharma Inc. | 2016-09-14 |
| A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA (NCT03147248) | Celltrion | 2016-09-12 |
| Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) (NCT02833350) | Genentech, Inc. | 2016-09-09 |
| Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy (NCT02930343) | Jawaharlal Institute of Postgraduate Medical Education & Research | 2016-09-01 |
| 2-week dc of MTX and Influenza Vaccination in RA (NCT02897011) | Seoul National University Hospital | 2016-09-01 |
| Low Dose Dexamethasone in Supraclavicular Blocks (NCT02666443) | University of Calgary | 2016-09-01 |
| CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis (NCT03953378) | Hospices Civils de Lyon | 2016-09-01 |
| Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis (NCT02831855) | Pfizer | 2016-09-01 |
| Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management (NCT02820038) | University of North Carolina, Chapel Hill | 2016-09-01 |
| Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis (NCT03011281) | Hanyang University | 2016-09-01 |
| Synovitis and Therapy Response in Inflammatory Arthritis With Contrast Enhanced Ultrasound (NCT02902562) | University of Southern California | 2016-08-31 |
| Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate (NCT02889796) | Gilead Sciences | 2016-08-30 |
| A Study of LY3337641 in Rheumatoid Arthritis (NCT02628028) | Eli Lilly and Company | 2016-08-22 |
| Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects (NCT02705989) | Bristol-Myers Squibb | 2016-08-18 |
| Use of Remote Monitoring by Smartphone in the Care Management of Patients With Rheumatoid Arthritis (NCT03005925) | University Hospital, Montpellier | 2016-08-16 |
| Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy (NCT02886728) | Gilead Sciences | 2016-08-08 |
| A Comparison of Two Electronic Gloves in the Measurement of Joint Movement in Patients With Rheumatoid Arthritis (NCT02026245) | University of Ulster | 2016-08-01 |
| Faecal Analyses in Rheumatoid Arthritis Therapy (NCT03775824) | Region Skane | 2016-08-01 |
| Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy Subjects (NCT02892370) | Jiangsu HengRui Medicine Co., Ltd. | 2016-08-01 |
| BE Study in Patients - Methotrexate Tablets (NCT02940561) | Amneal Pharmaceuticals, LLC | 2016-08-01 |
| Safety and Efficacy Study of M2951 in Participants With Rheumatoid Arthritis (NCT02784106) | EMD Serono Research & Development Institute, Inc. | 2016-07-31 |
| Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment (NCT02873936) | Gilead Sciences | 2016-07-27 |
| A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis (NCT02867306) | Astellas Pharma Global Development, Inc. | 2016-07-25 |
| Actis Total Hip System 2 Year Follow-up (NCT02783274) | DePuy Orthopaedics | 2016-07-01 |
| Periodontal Inflammation and Immunity in Preclinical Rheumatoid Arthritis (NCT02794012) | University of Colorado, Denver | 2016-07-01 |
| Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging (NCT02683421) | Navidea Biopharmaceuticals | 2016-07-01 |
| CorEvitas Japan Rheumatoid Arthritis (RA) Registry (NCT02737449) | CorEvitas | 2016-07-01 |
| Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid Arthritis (NCT02765074) | Centre Hospitalier Régional d'Orléans | 2016-06-30 |
| The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study (NCT02585258) | Amsterdam UMC, location VUmc | 2016-06-30 |
| Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj (NCT03106259) | Kang Stem Biotech Co., Ltd. | 2016-06-29 |
| Cardiovascular Profiles in Rheumatoid Arthritis (NCT03960515) | Maria Betânia Almeida Dias Ferreira | 2016-06-22 |
| Evaluation of Stem Cell Therapy Effects on the Immune Response in Rheumatoid Arthritis Patients (NCT03333681) | Mashhad University of Medical Sciences | 2016-06-20 |
| Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease (NCT03762824) | Region Skane | 2016-06-14 |
| Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings (NCT02758769) | Bristol-Myers Squibb | 2016-06-07 |
| Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease (NCT02760407) | R-Pharm International, LLC | 2016-06-06 |
| Association Between Subtypes of Anti Citrullinated Peptide Antibodies and Lung Damage in Rheumatoid Arthritis (NCT03832374) | University Hospital Center of Martinique | 2016-06-02 |
| A Time to Cardiovascular Event Analysis Comparing Tocilizumab to Other Biologics in Patients With Rheumatoid Arthritis (RA) (NCT02797769) | Hoffmann-La Roche | 2016-06-02 |
| Treatment Adherence to Injectable Methotrexate in Rheumatoid Arthritis (NCT02897817) | Nordic Pharma SAS | 2016-06-01 |
| Gum Arabic as Immunomodulator In Rheumatoid Arthritis Patients (NCT02804581) | Lamis Kaddam | 2016-06-01 |
| Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF (NCT02804204) | Hospital Universitari Vall d'Hebron Research Institute | 2016-06-01 |
| Clinical Follow-up of Anti-Carbamylated Antibody Status in Rheumatoid Arthritis (NCT02958319) | Universidad Autonoma de Nuevo Leon | 2016-06-01 |